Federated Hermes’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.11K | Sell |
|
|||||
|
2025
Q2 | $11.2K | Sell |
|
|||||
|
2025
Q1 | $38.5K | Buy |
|
|||||
|
2024
Q4 | $12.8K | Sell |
|
|||||
|
2024
Q3 | $16.8K | Sell |
|
|||||
|
2024
Q2 | $20.2K | Sell |
|
|||||
|
2024
Q1 | $160K | Sell |
|
|||||
|
2023
Q4 | $2.89M | Sell |
|
|||||
|
2023
Q3 | $2.29M | Buy |
|
|||||
|
2023
Q2 | $320K | Buy |
|
|||||
|
2023
Q1 | $1.11K | Sell |
|
|||||
|
2022
Q4 | $1.42K | Sell |
|
|||||
|
2022
Q3 | $2K | Sell |
|
|||||
|
2022
Q2 | $107K | Sell |
|
|||||
|
2022
Q1 | $5.17M | Sell |
|
|||||
|
2021
Q4 | $24.9M | Buy |
|
|||||
|
2021
Q3 | $11.1M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $25.8M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $161K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $3.6M | Sell |
|
|||||
|
2019
Q3 | $5.28M | Buy |
|
|||||
|
2019
Q2 | $2.46M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $2.11M | Sell |
|
|||||
|
2017
Q3 | $3.63M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $11.9M | Sell |
|
|||||
|
2016
Q2 | $16M | Hold |
|
|||||
|
2016
Q1 | $13.8M | Hold |
|
|||||
|
2015
Q4 | $17.5M | Sell |
|
|||||
|
2015
Q3 | $26.6M | Buy |
|
|||||
|
2015
Q2 | $25.3M | Sell |
|
|||||
|
2015
Q1 | $20.6M | Buy |
|
|||||
|
2014
Q4 | $3.17M | Buy |
|